1 中华医学会分会呼吸学组.儿童支气管哮喘诊断与防治指南.中华儿科杂志,2016,54:167-181. 2 王雅娟,赵一婷,戴斌,等.两种大鼠哮喘模型的比较.中国药理学通报,2014,8:1175-1178. 3 杨飞,惠毅,闫曙光,等.卵蛋白加氢氧化铝致敏建立哮喘大鼠模型研究.现代中西医结合杂志,2018,27:1600-1602. 4 劳文艳,阮研硕,周艳丽,等.两种大鼠哮喘模型建立方法的比较.北京联合大学学报:自然科学版,2017,3:54-58. 5 Ying W,Wollam J,Ofrecio JM,et al.Adipose tissue B2 cells promote insulin resistance through leukotriene LTB4/LTB4R1 signaling.J Clin Invest,2017,127:1019-1030. 6 Tu ZL,Zhou ZY,Xu HC,et al.LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats.J Cardiothorac Surg,2017,12:43. 7 顾丽英,唐华,陈洁,等.不同治疗方案对学龄期中度持续性支气管哮喘患儿的临床疗效对比.浙江医学,2018,40:152-155. 8 刘美璇,张倩,黄建浩,等.白三烯受体拮抗剂(LTRA)对哮喘-慢阻肺重叠(ACO)患者气道炎症的影响及相关机制.复旦学报(医学版),2018,45:98-103. 9 王正军,纪建兵,苏宝凤,等.白三烯受体拮抗剂治疗儿童支气管哮喘合并变应性鼻炎的临床效果.系统医学,2018,3:125-127. 10 曾文射,王科峰,黄智聪.孟鲁司特钠治疗小儿喘息性支气管炎的疗效及对气道高反应性的预防效果.吉林医学,2019,40:102-104. 11 Lee E,Robetson T,Smith J,et al.Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals.Am J Respir Crit Care Med,2000,161:1881-1886. 12 Lee E,Lindo T,Jackson N,et al.Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors.Am J Respir Crit Care Med 1999,160,2079-2085. 13 Tenero L,Piazza M,et al.Effect of montelukast on markers of airway remodeling in children with asthma.Allergy Asthma Proc,2016,37:77-83. 14 苗二梅.阿奇霉素联合孟鲁司特钠治疗小儿肺炎支原体肺炎的疗效及其对患儿T淋巴细胞亚群、免疫球蛋白及补体C3、C4的影响.中国实用医刊,2018,45:97-100. 15 施弦,郁峰.布地奈德联合孟鲁司特对支气管哮喘患儿炎性因子及免疫功能的影响.中国医药,2018,13:55-58.
